Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al
This is called vitamin B12 neuropathy
As a result , you may notice fast improvements in fatigue, weakness, and mood
It attacks the problem from both sides, targeting adipose tissue directly
The medications provided to manage blood sugar levels can also lead to B-12 deficiency, in addition to excessive blood sugar levels harming nerves
In life-threatening cases, 5,000,000mcg of B12 is given directly to the veins within a 15 minute window
US$ 21.48
US$ 24.97
US$ 24.89
US$ 23.62
US$ 24.73
US$ 20.75
US$ 28.16
